Inflammation in Diabetic Nephropathy

Inflammation in Diabetic Nephropathy

Diabetic nephropathy is the leading cause of end-stage kidney disease worldwide but current treatments remain suboptimal. This review examines the evidence for inflammation in the development and progression of diabetic nephropathy in both experimental and human diabetes, and provides an update on r...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autors principals:	Andy K.H. Lim, Greg H. Tesch
Format:	Revisão
Idioma:	anglès
Publicat:	2012
Accés en línia:	https://doi.org/10.1155/2012/146154 https://downloads.hindawi.com/journals/mi/2012/146154.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Inflammation in Diabetic Nephropathy
per: Lim, Andy K. H., et al.
Publicat: (2012)

Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
per: Andy K.H. Lim, et al.
Publicat: (2009)

Diabetic nephropathy &ndash; complications and treatment
per: Andy K.H. Lim
Publicat: (2014)

Diabetic nephropathy – complications and treatment
per: Lim, Andy KH
Publicat: (2014)

Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis
per: F. Y. Chow, et al.
Publicat: (2004)

Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
per: Andy K.H. Lim, et al.
Publicat: (2010)

Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
per: Fiona Chow, et al.
Publicat: (2003)

Diabetic nephropathy and inflammation
per: Montserrat B. Duran-Salgado
Publicat: (2014)

Diabetic nephropathy and inflammation
per: Duran-Salgado, Montserrat B, et al.
Publicat: (2014)

ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in <i>Nos3</i>-Deficient Mice
per: Greg H. Tesch, et al.
Publicat: (2015)

Epigenetics and Inflammation in Diabetic Nephropathy
per: Baoyi Shao, et al.
Publicat: (2021)

Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice
per: Fiona YF CHOW, et al.
Publicat: (2005)

Epigenetics and Inflammation in Diabetic Nephropathy
per: Shao, Bao-Yi, et al.
Publicat: (2021)

Role of MKK3–p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice
per: Andy K.H. Lim, et al.
Publicat: (2008)

Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
per: Juan F. Navarro‐González, et al.
Publicat: (2006)

Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy
per: L Adhikary, et al.
Publicat: (2004)

Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
per: Navarro, Juan F., et al.
Publicat: (2006)

Immune Cells and Inflammation in Diabetic Nephropathy
per: Zihan Zheng, et al.
Publicat: (2015)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
per: Shirong Zheng, et al.
Publicat: (2016)

Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy
per: Desirée Luis-Rodríguez
Publicat: (2012)

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
per: Qi Jin, et al.
Publicat: (2023)

Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy
per: Luis-Rodríguez, Desirée, et al.
Publicat: (2012)

Epac activation ameliorates tubulointerstitial inflammation in diabetic nephropathy
per: Yang, Wen-xia, et al.
Publicat: (2021)

Diabetic Nephropathy
per: Lionel H. Opie, et al.
Publicat: (2002)

Cellular Basis of Diabetic Nephropathy
per: Maria Luiza Caramori, et al.
Publicat: (2002)

Prognosis in diabetic nephropathy.
per: H.‐H. Parving, et al.
Publicat: (1989)

Diabetic nephropathy
per: Zelmanovitz, Themis, et al.
Publicat: (2009)

Prognosis in diabetic nephropathy.
per: Parving, H. H., et al.
Publicat: (1989)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
per: Keizo Kanasaki, et al.
Publicat: (2013)

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
per: Sandra Rayego‐Mateos, et al.
Publicat: (2020)

Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy
per: Susan B. Gurley, et al.
Publicat: (2018)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
per: Kanasaki, Keizo, et al.
Publicat: (2013)

Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy
per: Gurley, Susan B., et al.
Publicat: (2018)

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
per: Rayego-Mateos, Sandra, et al.
Publicat: (2020)

Abnormal liver function tests associated with severe rhabdomyolysis
per: Andy K.H. Lim
Publicat: (2020)

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients
per: Markku Saraheimo, et al.
Publicat: (2003)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
per: Julie Lin, et al.
Publicat: (2008)

Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
per: Miao Lin, et al.
Publicat: (2011)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
per: Lin, Julie, et al.
Publicat: (2008)

Silent diabetic nephropathy
per: Samar M. Said, et al.
Publicat: (2016)